A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies | MicrobiomeTrials← Back to trialsNCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2021-09-13Est. Completion: 2026-11
Enrollment target: 645 participants Locations- University of Alabama At Birmingham Hospital, Birmingham, Alabama, United States
- Mayo Clinic Phoenix, Phoenix, Arizona, United States
- Honor Health Research Institute, Scottsdale, Arizona, United States
- University of Arizona Cancer Center, Tucson, Arizona, United States
- University of California San Diego (Ucsd) Moores Cancer Center, La Jolla, California, United States
- Stanford Medicine, Palo Alto, California, United States
- UCLA Santa Monica Cancer Care, Santa Monica, California, United States
- Uchealth North, Fort Collins, Colorado, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami, Florida, United States
- Tampa General Hospital Cancer Institute, Tampa, Florida, United States
- Augusta University, Augusta, Georgia, United States
- Southeastern Regional Medical Center, Newnan, Georgia, United States
- Midwestern Regional Medical Center, Zion, Illinois, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Other microbiome trials you might be interested in
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is to ass…
Duarte, United StatesEst. completion Jul 2027
Non-hodgkin Lymphoma
The most common types of mature B-cell lymphomas (MBLs) in children are Burkitt lymphoma (BL) and diffuse large B-cell l…
Palo Alto, United StatesEst. completion Nov 2028
Norton Cancer Institute Pavilion, Louisville, Kentucky, United StatesMary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United StatesAmerican Oncology Partners of Maryland Pa, Bethesda, Maryland, United StatesDana Farber Cancer Institute, Boston, Massachusetts, United StatesKarmanos Cancer Institute, Detroit, Michigan, United StatesMayo Clinic Rochester, Rochester, Minnesota, United StatesComprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United StatesRoswell Park Comprehensive Cancer Center, Buffalo, New York, United StatesColumbia University Medical Center, New York, New York, United StatesWeill Cornell Medical College Newyork Presbyterian Hospital, New York, New York, United StatesMemorial Sloan Kettering Cancer Center Mskcc, New York, New York, United StatesTennesse Oncology Chattanooga Downtown, Chattanooga, Tennessee, United StatesTennessee Oncology, Pllc Nashville, Nashville, Tennessee, United StatesMd Anderson Cancer Center, Houston, Texas, United StatesVirginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United StatesFred Hutchinson Cancer Research Center, Seattle, Washington, United StatesConcord Repatriation General Hospital, Concord, New South Wales, AustraliaCalvary Mater Newcastle, Waratah, New South Wales, AustraliaPrincess Alexandra Hospital, Woolloongabba, Queensland, AustraliaSt Vincents Hospital Melbourne, Fitzroy, Victoria, AustraliaAustin Health, Heidelberg, Victoria, AustraliaPeter Maccallum Cancer Centre, Melbourne, Victoria, AustraliaThe Alfred Hospital, Melbourne, Victoria, AustraliaLinear Clinical Research, Nedlands, Western Australia, AustraliaPerth Blood Institute, West Perth, Western Australia, AustraliaHospital Sirio Libanes Brasilia, Brasília, BrazilHospital Erasto Gaertner, Curitiba, BrazilCentro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, BrazilReal E Benemerita Associacao Portuguesa de Sao Paulo, São Paulo, BrazilInstituto Dor de Pesquisa E Ensino Sao Paulo, São Paulo, BrazilHospital Nove de Julho Dasa, São Paulo, BrazilSociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, BrazilArthur Je Child Comprehensive Cancer Centre, Calgary, Alberta, CanadaCross Cancer Institute, Edmonton, Alberta, CanadaBritish Columbia Cancer Agency the Vancouver Centre, Vancouver, British Columbia, CanadaPrincess Margaret Cancer Centre, Toronto, Ontario, CanadaChu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Québec, Quebec, CanadaPeking Union Medical College Hospital, Beijing, Beijing Municipality, ChinaNanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaHenan Cancer Hospital, Zhengzhou, Henan, ChinaYichang Central Peoples Hospitaljiangnan Branch, Yichang, Hubei, ChinaRui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciencestuanbo Branch, Tianjin, Tianjin Municipality, ChinaThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaCentre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, FranceHopital Estaing, ClermontFerrand, FranceChu Henri Mondor, Créteil, FranceHopital Claude Huriez Chu Lille, Lille, FranceCentre Leon Berard, Lyon, FranceInstitut Paoli Calmettes, Marseille, FranceChu Montpellier Hopital Saint Eloi, Montpellier, FranceHopital de La Pitie Salpetriere, Paris, FranceCentre Henri Becquerel, Rouen, FranceArensia Exploratory Medicine Llc, Tbilisi, GeorgiaUniklinik Koeln (Aoer), Cologne, GermanyUniversitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden, GermanyUniversitares Krebszentrum Leipzig, Leipzig, GermanyUniversitaetsklinikum Schleswig Holstein Campus Luebeck, Lübeck, GermanyKlinikum Johannes Gutenberg Universitaet Mainz, Mainz, GermanyKlinikum Grosshadern Ludwig Maximilians Universitat Munchen, München, GermanyUniversitaetsklinikum Ulm, Ulm, GermanyPoliclinico Sorsola Malpighi, Aou Di Bologna, Bologna, ItalyOspedale San Raffaele, Milan, ItalyIstituto Europeo Di Oncologia, Milan, ItalyNiguarda Cancer Center Division of Hematology, Milan, ItalyFondazione Policlinico Universitario Agostino Gemelli, Roma, ItalyCentroricerche Cliniche Di Verona Srl, Verona, ItalyAichi Cancer Center Hospital Clinical Oncology, Nagoya, Aichi-ken, JapanChiba Cancer Center, Chiba, Chiba, JapanNational Cancer Center Hospital East, Kashiwa, Chiba, JapanCancer Institute Hospital of Jfcr, Kotoku, Tokyo, JapanYokohama Municipal Citizens Hospital, Yokohama, JapanThe Institute of Oncology, Arensia Exploratory Medicine, Chisinau, MoldovaInje University Busan Paik Hospital, BusanjinGu, Busan Gwang'Yeogsi, South KoreaPusan National University Hospital, Seogu, Busan Gwang'Yeogsi, South KoreaSamsung Medical Center, GangnamGu, Seoul Teugbyeolsi, South KoreaThe Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi, South KoreaSeverance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi, South KoreaSeoul National University Hospital, Seoul, Seoul Teugbyeolsi, South KoreaAsan Medical Center, SongpaGu, Seoul Teugbyeolsi, South KoreaHospital Universitario Vall Dhebron, Barcelona, SpainHospital General Universitario Gregorio Maranon, Madrid, SpainMd Anderson Cancer Center Madrid Spain, Madrid, SpainHospital Universitario Fundacion Jimenez Diaz, Madrid, SpainHospital Universitario La Paz, Madrid, SpainHospital Universitario Puerta de Hierro Majadahonda, Majadahonda, SpainHospital Clinico Universitario de Valencia, Valencia, SpainSahlgrenska University Hospital Hematology, Gothenburg, SwedenKarolinska Universitetssjukhuset Solna, Stockholm, SwedenDokuz Eylul University, Balçova, Turkey (Türkiye)Erciyes University, Kayseri, Turkey (Türkiye)Sakarya Training and Research Hospital, Sakarya, Turkey (Türkiye)Ondokuz Mayis University, Samsun, Turkey (Türkiye)Edinburgh Cancer Centre, Edinburgh, United KingdomSt Jamess University Hospital, Leeds, United KingdomFreeman Hospital, Newcastle upon Tyne, United KingdomGenesiscare Cambridge, Newmarket, United KingdomNorfolk and Norwich University Hospitals Nhs Foundation Trust, Norwich, United KingdomNottingham University Hospitals Nhs Trust, Nottingham, United KingdomDerriford Hospital, Plymouth, United KingdomContactStudy Director, MD
Urothelial CancerUrinary Bladder Neoplasms
This study is being done to see how well two drugs (enfortumab vedotin and pembrolizumab) work together as a bladder pre…
Santa Barbara, United StatesEst. completion Mar 31, 2030